|
Volumn 36, Issue 3, 2004, Pages 520-522
|
Donor pool expansion in liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
LAMIVUDINE;
ADULT;
AGED;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC THERAPY;
ARTERY DISEASE;
CADAVER DONOR;
CONFERENCE PAPER;
CONTROLLED STUDY;
FATTY LIVER;
FEMALE;
GRAFT SURVIVAL;
HEPATITIS C;
HUMAN;
HUMAN TISSUE;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
LIVER TRANSPLANTATION;
LIVER VEIN THROMBOSIS;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MALE;
ORGAN DONOR;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SAFETY;
SURGICAL MORTALITY;
SURGICAL TECHNIQUE;
TISSUE EXPANSION;
ADULT;
AGE FACTORS;
AGED;
CADAVER;
CAUSE OF DEATH;
FEMALE;
GRAFT SURVIVAL;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS C;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
TISSUE DONORS;
|
EID: 2042459149
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.02.020 Document Type: Conference Paper |
Times cited : (30)
|
References (6)
|